ST. LOUIS, Sept. 10, 2018 /PRNewswire/ -- This season, third-party trials conducted by growers and in collaboration with Aker are tracking plant health and yield results for Delaro®, a new corn and soybean fungicide from Bayer. As the season progresses, comparison images show the positive plant health benefits Delaro has on crops.
After applying fungicide, Aker uses high-resolution drones to capture multiple images of the fields. The results give growers a map, with red areas indicating less healthy plants and green representing healthy plants. The trials will also track yield comparisons.
"Monitoring a crop in season can help pinpoint if plants are under stress from things like disease," said Todd Golly, co-founder of Aker. "Using aerial imagery helps growers understand how to better optimize inputs, which can increase yield and profitability. It helps growers be more productive in the field."
Delaro provides broad-spectrum residual activity from dual modes of action, giving growers disease protection from day one through the end of the spray interval. This allows for consistent performance and better yields. It also improves plant health, allowing corn and soybeans to better handle stress.
"Trials in 2017 found that Delaro provided a substantial yield increase over the untreated check in corn and soybeans," said Ray Lello, fungicides product manager at Bayer. "However, we also consistently heard from trial participants that they observed improved plant health from Delaro. That's why we are thrilled to collaborate with Aker to track qualitative metrics like plant health in addition to the known quantitative yield results of Delaro over the untreated check in corn and soybeans. Understanding how these benefits help contribute to an overall return on investment is beneficial for growers as they look to get the most out of their corn hybrids and soybean varieties."
Delaro was first available for the 2018 growing season. Before its release, across two years of trials, Delaro averaged a 12-18 bushel per acre increase in corn and a 4-5 bushel per acre increase in soybeans compared to untreated checks. In these trials, Delaro had a 90 percent win rate over the untreated checks.
Aker is an in-season crop monitoring and autonomous scouting solution for farming globally. Aker enables proactive observation and directed scouting to alert of adverse environmental conditions impacting crop health and yield.
© 2018 Bayer CropScience LP, 800 North Lindbergh Blvd., St. Louis, MO 63167. Always read and follow label instructions. Bayer, the Bayer Cross and Delaro are registered trademarks of Bayer. Delaro is not registered in all states. For additional product information, call toll-free 1-866-99-BAYER (1-866-992-2937) or visit our website at www.cropscience.bayer.us.
Learn more at delaro.us and aker.ag.
Bayer is committed to bringing new technology and solutions for agriculture and non-agricultural uses. For questions concerning the availability and use of products, contact a local Bayer representative, or visit Crop Science, a division of Bayer, online at www.cropscience.bayer.us.
Visit the Bayer Connect - Social Hub for social media, recent news, blog posts, videos and more from Crop Science, a division of Bayer.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.us.
Bayer Media Hotline, 1-862-404-5118, or
Tel: (712) 363-0900
Rhea + Kaiser
Tel: (630) 955-2522
Find more information at www.cropscience.bayer.us.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.